Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2020
Summary Medical Devices sector report, “Glaucoma Surgery Devices - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Glaucoma Surgery Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Glaucoma surgery devices are used to augment normal physiologic aqueous outflow pathways in order to provide effective intra-ocular pressure. This category includes glaucoma drainage devices and canaloplasty micro catheters.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope - Extensive coverage of the Glaucoma Surgery Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Glaucoma Surgery Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry
Reasons to Buy The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Glaucoma Surgery Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date
Our reports have been used by over 10K customers, including:
Summary Cochlear Ltd (Cochlear) is a medical device company that offers implantable hearing solutions.It develops, manufactures and markets electronic implantable hearing devices. The company’s products are suited for people with hearing loss caused by ear nerve damage.Its major products include cochlear implant...
Summary Compumedics Ltd (Compumedics) is a medical device company.It develops and commercializes computer-based medical products. The company designs, develops and commercializes computer aided medical diagnostic systems.It provides product categories such as sleep diagnostics, neurology diagnostics, brain research...
The research antibodies and reagents market is projected to reach USD 14.1 billion by 2025 from USD 10.1 billion in 2020, at a CAGR of 6.7% during the forecast period. The research antibodies and reagents market has evolved owing to factors such as growth in proteomics and genomics research, rising demand for high-quality antibodies for research...
2020 Diarrhea PIPELINE HIGHLIGHTS
Diarrhea is one of the widely researched conditions during 2020 with 29 companies actively focusing on realizing pipeline’s potential. Development of Diarrhea medicines is identified as integral to the strategy of the majority of companies operating in the industry.
Biochips are being increasingly used in the area of biomedical and biotechnological research. With the advancement of technology in the medical field, there has been a rise in adoption of biochips in proteomics, such as in microarrays. The advantages of protein biochips include low sample consumption and its inclination towards miniaturization....
415 pages •
By The Business Research Company
• Mar 2020
Contract Research Organizations (CRO) Global Market Opportunities And Strategies To 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global Contract Research Organizations (CRO) market. Description: Where is the largest and fastest growing market...
Rising demand for ATP assays in pharmaceutical and biotechnology companies The global ATP assays market is projected to reach USD 315 million by 2024 from USD 191 million in 2019, at a CAGR of 10.5%. Growth in this market is majorly driven by the increasing demand for ATP assays in pharmaceutical and biotechnology companies,...
Market Overview The key factors propelling the whole slide imaging market are increasing usage in drug discovery processes, technological advancements in whole slide imaging, and rising popularity of virtual slides, as compared to physical slides. Also, the increasing incidence of cancer is expected to drive the growth...
116 pages •
By Infiniti Research Limited
• Jun 2018
About Healthcare Contract Research and Manufacturing Outsourcing (CRO) Healthcare contract research outsourcing can be defined as the services offered by contract research organizations (CROs) for the development of drugs and manufacture of medical devices. It includes additional services such as product approvals,...
Opportunity Analyzer: Idiopathic Pulmonary Fibrosis - Opportunity Analysis and Forecast to 2025 Summary The IPF therapeutic market is currently dominated by the only two drugs that have gained marketing approval for IPF - Roche’s Esbriet and Boehringer Ingelheim’s Ofev. Esbriet was the first drug to gain approval...
Commercial Real Estate
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.